|Articles|April 1, 2013

Anti-VEGF therapy for the treatment of glaucoma

Early reports on off-label uses for anti-VEGFs are promising

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Latest CME